BioAtla, Inc. (BCAB) Tops Q2 EPS by 1c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Trump on war in Ukraine: Putin does feel pressure, end closer than people realize
• Raymond James cuts Delta and JetBlue ratings ahead of Q2 earnings
• Active options: INTC AMD META MU PLTR PEP MSTR NFLX GOOGL CRWV